+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Modafinil improves behavioral alertness in patients with Obstructive Sleep Apnea (OSA) treated with Nasal Continuous Positive Airway Pressure (nCPAP) with Residual Excessive Sleepiness (ES)



Modafinil improves behavioral alertness in patients with Obstructive Sleep Apnea (OSA) treated with Nasal Continuous Positive Airway Pressure (nCPAP) with Residual Excessive Sleepiness (ES)








Accession: 021355369

Download citation: RISBibTeXText


Related references

Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep 28(4): 464-471, 2005

Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure. Sleep Medicine 27-28: 45-48, 2016

Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study. Journal of Clinical Sleep Medicine 9(8): 751-757, 2013

Residual excessive sleepiness in patients with obstructive sleep apnea on treatment with continuous positive airway pressure. Current Opinion in Pulmonary Medicine 22(6): 589-594, 2016

The effects of nasal continuous positive airway pressure ncpap on sleepiness and psychological functioning in obstructive sleep apnea osa. American Review of Respiratory Disease 145(4 Part 2): A168, 1992

Residual excessive daytime sleepiness in patients with obstructive sleep apnea treated with positive airway pressure therapy. Sleep and Breathing 2019:, 2019

Differential gene expression in the T-helper lymphocytes of obstructive sleep apnea patients treated with nasal continuous positive airway pressure (nCPAP). Medical Hypotheses 63(4): 630-632, 2004

Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study. Sleep Medicine 14(10): 955-963, 2013

Positron emission tomography findings in obstructive sleep apnea patients with residual sleepiness treated with continuous positive airway pressure. Journal of Physiology and Pharmacology 58 Suppl 5(Pt 1): 25-35, 2007

Positron emission tomography findings in obstructive sleep APNEA patients with residual sleepiness treated with continuous positive airway pressure. Journal of Physiology and Pharmacology 58(Suppl. 5, Part 1): 25-35, 2007

The effects of nasal continuous positive airway pressure ncpap on sleepiness and psychological functioning in obstructive apnea osa. Clinical and Investigative Medicine 15(4 Suppl.): A143, 1992

Impact of nasal continuous positive airway pressure ncpap on breathing route in patients with obstructive sleep apnea osa. American Review of Respiratory Disease 141(4 Part 2): A862, 1990

Risk of interrupting nocturnal nasal continuous positive airway pressure (nCPAP) in patients with obstructive sleep apnea. Deutsche Medizinische Wochenschrift 135(17): 868-869, 2010

Residual Sleepiness On Continuous Positive Airway Pressure (Cpap) Therapy In Patients With Obstructive Sleep Apnea (Osa). Sleep 40(Suppl_1): A190-A191, 2017

Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure. Journal of Sleep Research 22(4): 389-397, 2013